AU2001296448A1 - Tumor marker and methods of use - Google Patents

Tumor marker and methods of use

Info

Publication number
AU2001296448A1
AU2001296448A1 AU2001296448A AU9644801A AU2001296448A1 AU 2001296448 A1 AU2001296448 A1 AU 2001296448A1 AU 2001296448 A AU2001296448 A AU 2001296448A AU 9644801 A AU9644801 A AU 9644801A AU 2001296448 A1 AU2001296448 A1 AU 2001296448A1
Authority
AU
Australia
Prior art keywords
methods
tumor marker
tumor
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296448A
Inventor
Susan Mcdonald Goldsworthy
David Erik Jensen
Traci Ann Mansfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
CuraGen Corp
Original Assignee
Glaxo Group Ltd
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, CuraGen Corp filed Critical Glaxo Group Ltd
Publication of AU2001296448A1 publication Critical patent/AU2001296448A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001296448A 2000-10-03 2001-10-01 Tumor marker and methods of use Abandoned AU2001296448A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23760500P 2000-10-03 2000-10-03
US60/237,605 2000-10-03
PCT/US2001/030682 WO2002029104A2 (en) 2000-10-03 2001-10-01 Tumor marker and methods of use

Publications (1)

Publication Number Publication Date
AU2001296448A1 true AU2001296448A1 (en) 2002-04-15

Family

ID=22894424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296448A Abandoned AU2001296448A1 (en) 2000-10-03 2001-10-01 Tumor marker and methods of use

Country Status (5)

Country Link
US (1) US20050064402A1 (en)
EP (1) EP1425410A2 (en)
JP (1) JP2004510442A (en)
AU (1) AU2001296448A1 (en)
WO (1) WO2002029104A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599606A1 (en) * 2003-03-03 2005-11-30 Arizona Board of Regents on behalf of The University of Arizona Protein tyrosine phosphatase - prl-1 a a marker and therapeutic target for pancreatic cancer
WO2005029067A2 (en) * 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Method of diagnosing breast cancer
US7332253B1 (en) * 2006-07-27 2008-02-19 Eastman Kodak Company Negative-working radiation-sensitive compositions and imageable materials
EP2057187B1 (en) 2006-08-10 2016-12-28 Oncotherapy Science, Inc. Genes and polypeptides relating to breast cancers
US8455196B2 (en) * 2011-05-23 2013-06-04 Jin-Mei Lai Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
MX355759B (en) 2011-10-28 2018-04-27 Oncotherapy Science Inc Topk peptides and vaccines including the same.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043342A (en) * 1997-11-10 2000-03-28 Beth Israel Deaconess Medical Center PDZK1 protein containing PDZ interaction domains
WO2000006728A2 (en) * 1998-07-28 2000-02-10 Incyte Pharmaceuticals, Inc. Phosphorylation effectors
US6656698B1 (en) * 1999-06-30 2003-12-02 Millennium Pharmaceuticals, Inc. 12832, a novel human kinase-like molecule and uses thereof
US6558903B1 (en) * 1999-06-30 2003-05-06 Millennium Pharmaceuticals, Inc. Kinases and uses thereof
WO2001053836A2 (en) * 2000-01-24 2001-07-26 Millennium Pharmaceuticals, Inc. Identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
JP2004510442A (en) 2004-04-08
EP1425410A2 (en) 2004-06-09
WO2002029104A3 (en) 2003-10-02
WO2002029104A8 (en) 2004-04-08
US20050064402A1 (en) 2005-03-24
WO2002029104A2 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU3726400A (en) Magnetic anatomical marker and method of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU6340600A (en) Telomerase inhibitors and methods of their use
AU2002224808A1 (en) Use of thienopyrimidines
AU2001280179A1 (en) Production and use of octafluoropropane
AU2001285244A1 (en) Prostate visualization device and methods of use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU7129700A (en) Ovarian tumor sequences and methods of use therefor
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2001273052A1 (en) Antifungal compounds and methods of use
AU2002365202A1 (en) Synthetic genes for malarial proteins and methods of use
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001296448A1 (en) Tumor marker and methods of use
AU2002248213A1 (en) Markers for disease susceptibility and targets for therapy
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
EP1263935A4 (en) Scytonemin and methods of using thereof
AU2002227272A1 (en) Ovarian tumor antigen and methods of use therefor
AU2001279090A1 (en) Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
AU2002218977A1 (en) Novel marker for the diagnosis and therapy of tumours